Call for Abstract

17th Global Neuroscience Conference, will be organized around the theme “Neuroscience Across the Lifespan, Amelioration of Neuroscience”

Neuroscience 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Neuroscience 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Neurological disorders
  • Track 1-2Neuro-developmental disorders
  • Track 1-3Pediatric Neurological Disorders
  • Track 1-4Dural Arteriovenous Fistulae
  • Track 1-5Post-Herpetic Neuralgia
  • Track 1-6Stroke
  • Track 1-7Recent treatments for Neurological Disorders
  • Track 1-8Amyotrophic lateral sclerosis
  • Track 2-1Psychophysical experiments
  • Track 2-2Developmental cognitive neuroscience
  • Track 2-3Cognitive Neuro-psycology
  • Track 2-4Functional neuro-imaging
  • Track 2-5Cognitive genomics
  • Track 2-6Molecular and cellular cognition
  • Track 2-7Neuro-linguistics
  • Track 2-8Social neuroscience
  • Track 2-9Systems neuroscience
  • Track 3-1Central Nervous System
  • Track 3-2CNS Pharmacology
  • Track 3-3Biomarkers and its role on CNS
  • Track 3-4Morphology and functions
  • Track 3-5Neural coding
  • Track 3-6Neural modulation
  • Track 3-7Synaptic and circuit dynamics
  • Track 3-8Clinical Trails on CNS
  • Track 3-9Clinical Trails on CNS
  • Track 4-1Vascular neuro-surgery
  • Track 4-2Endovascular neuro-surgery
  • Track 4-3Functional neuro-surgery
  • Track 4-4Oncological neuro-surgery
  • Track 4-5Skull base surgery
  • Track 4-6Spinal neuro-surgery
  • Track 4-7Neuropsychiatric surgery
  • Track 4-8Pediatric neuro-surgery
  • Track 4-9Stereotactic neuro-surgery
  • Track 4-10Epilepsy surgery
  • Track 4-11Geriatric neuro-surgery
  • Track 4-12Latest advancements in Neuro-surgery
  • Track 5-1Metastatic Cancer
  • Track 5-2Pediatric Neuro-oncology
  • Track 5-3Angiogenesis in Neuro-oncology
  • Track 5-4Brain and Spinal Cord tumours
  • Track 5-5Diagnosis and case study in Neuro-oncology
  • Track 5-6Glioblastoma
  • Track 5-7Pain Management in Neuro-oncology
  • Track 5-8Radiation Oncology
  • Track 5-9Tumour Heterogeneity
  • Track 5-10Psychosocial Advances in Neuro-oncology
  • Track 6-1Friedreich ataxia
  • Track 6-2Alzheimers disease
  • Track 6-3Parkinsons disease
  • Track 6-4Huntingtons disease
  • Track 6-5Prion disease
  • Track 6-6Toxic encephalopathy
  • Track 6-7Spinocerebellar ataxia
  • Track 6-8Motor neurone diseases
  • Track 6-9Spinal muscular atrophy
  • Track 7-1central and peripheral nervous system
  • Track 7-2Clinical neuro-physiology
  • Track 7-3Neurostimulation
  • Track 7-4Neuro-physiological monitoring
  • Track 7-5Novel diagnostic neuro-physiological methods
  • Track 7-6Electroencephalography,Electromyography
  • Track 8-1Genetic Mutation
  • Track 8-2Behavioral Neuro-genetics
  • Track 8-3Biomarkers used in Neuro-genetics
  • Track 8-4Biochemical genetics
  • Track 8-5Recent developments of neuro-genetics
  • Track 8-6Current treatment for neuro-genetic disorders
  • Track 8-7Advance therapies for genetic disorders
  • Track 9-1Neuropeptides- β-endorphinand cholecystokinin
  • Track 9-2Cholinergic and aminoacidergic Neurotrasmitters
  • Track 9-3Monoaminergic and Purinergic Neurotransmitters
  • Track 9-4Chromaffin Granules- catecholamines and Epinephrine
  • Track 9-5Molecular, Cellular and Medical Aspects
  • Track 9-6Advancements in Neuro-chemistry
  • Track 10-1Molecular and cellular data
  • Track 10-2Data from organs and systems
  • Track 10-3Neuro-informatics Portal Pilot
  • Track 10-4Neuronal Time Series Analysis
  • Track 10-5The Blue Brain Project
  • Track 10-6Modern informatics helps in understanding brain diseases
  • Track 10-7Neuro-informatics and Computational Neuroscience
  • Track 10-8Neural engineering data
  • Track 11-1Clinical Neuro-immunology and disorders
  • Track 11-2Neuro immunogenetics
  • Track 11-3Psychoneuroimmunology
  • Track 11-4Antibody-mediated disorders
  • Track 11-5Neuro-Immune Interaction and adverse affects
  • Track 11-6Guillain-Barre syndrome & other autoimmune neuropathies
  • Track 11-7Neuroimmunological Infectious diseases
  • Track 11-8Neuro developmental Disorders
  • Track 11-9Neuro-immunology test
  • Track 11-10Neuro-immunogenetics
  • Track 11-11Neuro-inflammation and Inflammatory myopathies
  • Track 12-1A Novel Diagnostic tools in Neuro-ophthalmology
  • Track 12-2Color Vision Deficits in Multiple Sclerosis
  • Track 12-3Optic nerve disorder
  • Track 12-4Ophthalmic diseases
  • Track 12-5Lid and Lacrimal Reconstruction
  • Track 12-6Optic Neuritis After Refractive Surgery
  • Track 12-7Optic neuropathy
  • Track 13-1Neuro-immune Pharmacology
  • Track 13-2Recent Drug Development
  • Track 13-3Cosmetic Neuro-pharmacology
  • Track 13-4Cosmetic Neuro-pharmacology
  • Track 13-5Chemical Neurotransmitters
  • Track 13-6Behavioral Neuro-pharmacology
  • Track 13-7Psycho-pharmacology
  • Track 13-8Clinical Neuro-pharmacology
  • Track 13-9Molecular Neuro-pharmacology
  • Track 13-10Psychopharmaceuticals
  • Track 14-1Neuro-imaging techniques in detection of Clinical neuro-toxicity
  • Track 14-2Behavioral Neuro-toxicity testing
  • Track 14-3Neuro-toxicological epidemiology
  • Track 14-4Exposured and risk assessment on neuro-toxicity
  • Track 14-5Neuro-toxins and its effects
  • Track 14-6Latest Therapies use in Neuro-toxicity
  • Track 15-1Schizophrenia: Behavioral Disorder
  • Track 15-2Bipolar Disorder
  • Track 15-3Post-Traumatic Stress Disorder
  • Track 15-4Depression
  • Track 15-5Obsessive-compulsive disorder
  • Track 15-6Visual hallucination
  • Track 15-7Auditory hallucination
  • Track 15-8Movement disorders and Social cognition
  • Track 15-9Challenges in tourettes syndrome
  • Track 15-10Neuro-psychaitry- past, present and future aspirations
  • Track 15-11Anxiety
  • Track 16-1Ethical Considerations in Neuro-science Nursing
  • Track 16-2Pre operative care for neuro-surgery
  • Track 16-3Post operative care
  • Track 16-4Rehabilitation nursing
  • Track 16-5Psychiatric nursing
  • Track 16-6Affective neuro-science
  • Track 17-1Intracerebral haemorrhage
  • Track 17-2Subdural haemorrhage
  • Track 17-3Intra-ventricular haemorrhage diseases
  • Track 17-4Guillain-Barre Syndrome
  • Track 17-5Acute ischemic stroke
  • Track 17-6Intracranial or subarachnoid haemorrhage
  • Track 17-7Cerebral aneurysm
  • Track 17-8Cerebrovascular malformations
  • Track 17-9Coma
  • Track 17-10Encephalopathy
  • Track 17-11Hydrocephalus
  • Track 17-12Traumatic brain injury
  • Track 17-13Acute spine injury
  • Track 17-14Seizures (prolonged or continuous)
  • Track 17-15Severe or deteriorating demyelinating illness
  • Track 17-16Meningitis
  • Track 17-17Encephalitis
  • Track 17-18Spinal infection
  • Track 17-19Neuro-muscular disorders
  • Track 17-20Autonomic instability
  • Track 18-1Advancements in Stem cells treatment
  • Track 18-2Nerve injury and repair
  • Track 18-3Cell and gene based approach
  • Track 18-4Neuro interventions
  • Track 18-5Molecular Mechanisms
  • Track 18-65-HT, Serotonin in Levodopa therapy
  • Track 18-7Recent Advancements in Anxiety Disorder
  • Track 18-8Inflammation Mediators and Stroke
  • Track 18-9Neuro-trophic Factor for Pain
  • Track 19-1Peripheral neuropathy
  • Track 19-2Cranial neuropathy
  • Track 19-3Diabetic neuropathy
  • Track 19-4Familial amyloid neuropathies
  • Track 19-5Giant axonal neuropathy
  • Track 19-6Polyneuropathy
  • Track 19-7Organophosphate-induced delayed neuropathy
  • Track 19-8Neuropathy, ataxia, and retinitis pigmentosa
  • Track 20-1Neural Implantation
  • Track 20-2Neuroethics
  • Track 20-3Neural stem cell therapy
  • Track 20-4Brain-Computer Interface
  • Track 20-5Translational Neuroscience